Byooviz 10 mg/mL
ranibizumab-nuna · INJECTION, SOLUTION · BIOGEN INC.
Byooviz is an injectable medication that works by blocking vascular endothelial growth factor (VEGF) to help treat certain eye conditions involving abnormal blood vessel growth. It is administered as an injection directly into the eye and is used to treat conditions such as wet age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion.
Key Facts
- Brand Name
- Byooviz
- Generic Name
- ranibizumab-nuna
- NDC Code (Product)
64406-019- Manufacturer
- BIOGEN INC.
- Strength
- 10 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVITREAL
- Marketing Status
- Application #
- BLA761202
- Drug Class
- Vascular Endothelial Growth Factor Inhibitor [EPC]
- Marketing Start
- 06/01/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is Byooviz used for?
Byooviz is an injectable medication that works by blocking vascular endothelial growth factor (VEGF) to help treat certain eye conditions involving abnormal blood vessel growth. It is administered as an injection directly into the eye and is used to treat conditions such as wet age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion.
Is Byooviz a controlled substance?
Byooviz is not classified as a controlled substance by the DEA.
What is the generic name for Byooviz?
The generic name for Byooviz is ranibizumab-nuna. There are no other listed brand versions of ranibizumab-nuna.
What is the NDC code for Byooviz 10 mg/mL?
The NDC (National Drug Code) for Byooviz 10 mg/mL is 64406-019, listed by BIOGEN INC..
Other Byooviz Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)